M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity —— Enhancements Strengthen ...

Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments ...

Senior Director Paul Praveen Kumar Ashok’s peer-reviewed research charts a new course for enterprise ERP systems — from ...

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

With Renishaw and Apex Additive Technologies, Addiguru is working to combine its multi-sensor monitoring platform, integrating optical, near-infrared (NIR), and long-wave infrared (LWIR) sensing, with ...

BioDuro and Cenra launch joint venture to expand resilient global API manufacturing capacity: Irvine Californa Thursday, March 5, 2026, 14:00 Hrs [IST] BioDuro, a globally trusted ...

Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade Two new ...

From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...

Supported by favourable policies, rising domestic demand and shift towards complex active pharmaceutical ingredient (API), the Indian API market is projected to grow at a compounded annual growth rate ...